| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/02/2004 | EP1373217A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors |
| 01/02/2004 | EP1373216A1 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/02/2004 | EP1373210A1 Heterocyclic diamide invertebrate pest control agents |
| 01/02/2004 | EP1373206A1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 01/02/2004 | EP1373204A2 Heterocyclic compounds |
| 01/02/2004 | EP1373203A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 01/02/2004 | EP1373194A1 BENZAMIDE INHIBITORS OF FACTOR Xa |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1372657A2 A method of treating proliferative diseases using eg5 inhibitors |
| 01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
| 01/02/2004 | EP1372654A2 Quinoline inhibitors of hyak1 and hyak3 kinases |
| 01/02/2004 | EP1372653A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/02/2004 | EP1372651A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity |
| 01/02/2004 | EP1036062B1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 01/02/2004 | EP0836595B1 Triazoline and isoxazoline bis-oxime derivatives and their use as pesticides |
| 01/01/2004 | US20040002608 Central nervous system disorders |
| 01/01/2004 | US20040002604 Phenylalkynes |
| 01/01/2004 | US20040002531 Imidazolyl derivatives |
| 01/01/2004 | US20040002527 Indolylalkylidenehydrazine-carboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002515 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 01/01/2004 | US20040002509 Novel substituted imidazole compounds |
| 01/01/2004 | US20040002508 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 01/01/2004 | US20040002507 Rho-kinase inhibitors |
| 01/01/2004 | US20040002504 Psychological disorders; schizophrenia |
| 01/01/2004 | US20040002503 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 01/01/2004 | US20040002501 Modulate signal transduction; antitumor, anticancer agents, vision defects, antidiabetic agents, antiinflammatory agents |
| 01/01/2004 | US20040002495 Lactam glycogen phosphorylase inhibitors and method of use |
| 01/01/2004 | US20040002494 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002487 Bone disorders; osteoporosis; oral diseases; antiarthritic agents |
| 01/01/2004 | US20040002461 Amelioration of the development of cataracts and other ophthalmic diseases |
| 01/01/2004 | US20040002424 2-Amino-4-bicyclylamino-6H-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators |
| 12/31/2003 | WO2004000833A1 Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 12/31/2003 | WO2004000831A1 Indole derivatives useful as histamine h3 antagonists |
| 12/31/2003 | WO2004000830A1 Novel compounds, their use and preparation |
| 12/31/2003 | WO2004000829A1 Novel process |
| 12/31/2003 | WO2004000828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
| 12/31/2003 | WO2004000816A1 Androgen receptor agonist |
| 12/31/2003 | WO2004000814A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | WO2004000812A1 Process for production of phenoxy-substituted 2-pyridone compounds |
| 12/31/2003 | WO2004000811A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | WO2004000808A2 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/31/2003 | WO2004000807A1 Cannabinoid receptor agonists |
| 12/31/2003 | WO2004000806A1 Amides of cyclic amino acids used as pde 4 inhibitors |
| 12/31/2003 | WO2004000800A2 Electrochromic salts, solutions, and devices |
| 12/31/2003 | WO2004000218A2 Method for making aryl hydrazines and substituted indoles |
| 12/31/2003 | WO2003078358A3 Use of microfabricated devices for radiosynthesis |
| 12/31/2003 | WO2003074513A3 Indole amide derivatives and their use as glycogen phosphorylase inhibitors |
| 12/31/2003 | WO2003065991A3 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 12/31/2003 | WO2003060475A3 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 12/31/2003 | WO2003059269A3 Acridone inhibitors of impdh enzyme |
| 12/31/2003 | CN1132832C Prepn process of 3-methyl-4 [(3-methoxy) propoxy]2-radical-methyl-thio-benzimidazole |
| 12/31/2003 | CN1132819C 作为TNF－α抑制剂的环状肼衍生物 Examples of the cyclic hydrazine derivative TNF-α inhibitors |
| 12/31/2003 | CN1132817C Process for preparation of heteroarylcarboxamides |
| 12/31/2003 | CN1132816C 2－吡啶基甲胺衍生物及其应用和杀虫剂组合物 2-pyridyl methyl amine derivatives and their application and insecticidal composition |
| 12/31/2003 | CN1132814C 含有磺酰胺的吲哚化合物 Sulfonamide-containing indole compound |
| 12/31/2003 | CN1132579C 脱乙氧羰基氯雷他定的无乳糖、非吸湿性及无水的药物组合物 De-ethoxycarbonyl loratadine lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions |
| 12/31/2003 | CA2490646A1 Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors |
| 12/31/2003 | CA2490397A1 N-substituted piperidine derivatives as serotonin receptor agents |
| 12/31/2003 | CA2490043A1 8-(biaryl) quinoline pde4 inhibitors |
| 12/31/2003 | CA2489375A1 Method for making aryl hydrazines and substituted indoles |
| 12/31/2003 | CA2487346A1 Cannabinoid receptor agonists |
| 12/31/2003 | CA2486989A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 12/31/2003 | CA2485537A1 Novel compounds, their use and preparation |
| 12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
| 12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
| 12/30/2003 | US6670380 Pyridone inhibitors of fatty acid binding protein and method |
| 12/30/2003 | US6670379 Piperidine compounds for use as ccr-3 inhibitors |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/30/2003 | US6670366 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 12/30/2003 | US6670354 Methods to enhance white blood cell count |
| 12/30/2003 | CA2266015C Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 12/29/2003 | CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 12/25/2003 | WO2003105853A1 1-aryl-4-substituted piperazines derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 12/25/2003 | WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
| 12/25/2003 | US20030236420 Pharmaceuticals |
| 12/25/2003 | US20030236416 Hydroxamic and carboxylic acid derivatives |
| 12/25/2003 | US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors |
| 12/25/2003 | US20030236411 Antisecretory agents for treating a peptic ulcer |
| 12/25/2003 | US20030236402 A caspase-3 enzyme inhibitors, 3-(3-alkyl-amino-2-oxo-1,2-dihydro-1-pyrazinyl-alkanoylamino) -4-oxopentanoic acid; treating cardiac or cerebral ischemia or reperfusion injury, diabetes, AIDS |
| 12/25/2003 | US20030236401 Asymmetric synthesis of amino-pyrrolidinones |
| 12/25/2003 | US20030236294 Anticancer agents |
| 12/25/2003 | US20030236282 Cardiovascular disorders; antiinflammatory agents; skin disorders |
| 12/25/2003 | US20030236281 Quinoline derivatives(2) |
| 12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 12/25/2003 | US20030236274 Naphthalene derivatives, their production and use |
| 12/25/2003 | US20030236267 Benzimidazole derivatives |
| 12/25/2003 | US20030236262 Dietetics; antidiabetic agents; sexual disorders |
| 12/25/2003 | US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
| 12/25/2003 | US20030236259 Novel aryl- and heteroarylpiperazines |
| 12/25/2003 | US20030236258 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 12/25/2003 | US20030236256 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives |
| 12/25/2003 | US20030236254 Novel heterocyclic compounds having hypolipidemic, hypocholesteremic activities process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 12/25/2003 | US20030236251 Hepatitis virus viricides |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030236248 Kappa agonist compounds and pharmaceutical formulations thereof |
| 12/25/2003 | US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal |